secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevation Oncology, Inc. (—)
CIK:        0001783032
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001558370-25-004266
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Elevation Oncology CMO Valerie Jansen departs; severance includes 9-month salary and equity vesting
--------------------------------------------------------------------------------

- CMO Valerie Jansen stepped down effective March 31, 2025.
- Separation agreement provides lump-sum payment equal to 9 months of salary.
- COBRA premium reimbursement for up to 9 months post-separation.
- Accelerated vesting of equity awards for shares that would have vested over 9 months.
- No successor CMO named; company has not disclosed a replacement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783032/000155837025004266/0001558370-25-004266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783032/000155837025004266/elev-20250331x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-004266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer